Hyperprolactinaemia promotes weight gain, obesity and the development of metabolic syndrome by inhibiting physiological dopaminergic tone and disrupting glucose–insulin and lipid metabolism. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.